Filtered By:
Management: Economics
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 211 results found since Jan 2013.
Pharmacoeconomic advantages of subcutaneous versus intravenous immunoglobulin treatment in a Canadian pediatric center
Although the data in the literature indicate that both subcutaneous (SC) and intravenous (IV) routes of administration of immunoglobulin (SC-Ig and IV-Ig) therapy are considered equivalent in terms of efficacy for patients with primary immunodeficiency, the question of the cost effect of this treatment remains an important economics question. Some pharmacoeconomic studies that compared SC-Ig with IV-Ig therapy have been performed in various countries, but their conclusions were not unequivocal, and, as reviewed by Membe et al, those studies could not be transposed to the Canadian or US health system.
Source: Journal of Allergy and Clinical Immunology - October 4, 2012 Category: Allergy & Immunology Authors: Thierry Ducruet, Marie-Claude Levasseur, Anne Des Roches, Ayman Kafal, Renée Dicaire, Elie Haddad Tags: Letters to the Editor Source Type: research
